期刊文献+

糖尿病及急性冠状动脉综合征患者ApoB与ApoA1比值测定的临床意义 被引量:9

Clinical significance of serum apolipoprotein B/A1 ratio in patients with diabetes mellitus and acute coronary syndrome
原文传递
导出
摘要 目的:研究糖尿病及急性冠状动脉综合征(ACS)患者血清载脂蛋白B(ApoB)与载脂蛋白A1(ApoA1)比值的变化并探讨其临床意义。方法:从体检人群中筛选可排除诊断为糖尿病及ACS的受检者33例为对照组、从住院患者中筛选临床确诊的单纯糖尿病患者47例、无糖尿病的ACS患者101例及ACS并发糖尿病患者52例,收集临床资料并分别检测各组空腹血糖、血脂和高敏C反应蛋白(hsCRP)水平。结果:糖尿病组、ACS非糖尿病组、ACS并发糖尿病组ApoB/ApoA1比值显著高于对照组(0.86±0.18、0.87±0.20、0.89±0.23)∶(0.76±0.15),均P<0.05。但3个患病组之间ApoB/ApoA1比值差异无统计学意义。高ApoB/ApoA1组(上4分位组)与低ApoB/ApoA1比较,BMI、FPG、TG、TC、LDL-C、hsCRP水平,糖尿病、高血压及ACS患病率均显著升高,而HDL-C水平则无显著变化。ROC曲线显示,ApoB/ApoA1较LDL-C具有更好的ACS诊断性能。结论:ApoB/ApoA1比值能较准确、灵敏地反映从糖尿病到ACS病程中脂代谢紊乱,并可用于对糖尿病预后及ACS发病风险的评估。 Objective:To assay the changes of serum apolipoprotein B/A1 ratio in subjects with diabetes melli- tus(DM) and acute coronary syndrom (ACS) ,and evaluate the clinical signification of apolipoprotein B/A1 ratio in risk assessment of DM and ACS. Method: A total of 33 cases without DM and ACS from health examination people were enrolled as control group,200 subjects (including 47 subjects with DM, 101 subjects with ACS but without DM and 52 subjects with DM and ACS) were selected from in-patients and divided into 3 patient groups. Clinical data of each subject were collected,meanwhile fasting plasma glucose(FPG), plasma lipid, high-sensitivity C reac- tive protein (hsCRP) were determined respectively. Result: Serum apolipoprotein B/A1 ratio in 3 patient groups were significantly higher than that of control group [(0.86±0.18,0.87±0.20,0.89±0.23) vs (0.76±0.15),P〈0.05] ,but there were no significantly difference in apolipoprotein B/A1 ratio between 3 patient groups. Com- pared with the highest quartile of apolipoprotein B/A1 ratio, BMI, FPG, TC, TG, LDL-C, hsCRP, and the preva lence rate of hypertension,DM and ACS were significantly higher than those of low B/A1 ratio group,but no sig- nificantly difference in HDL-C levels were existed;ROC showed that apolipoprotein B/A1 ratio was better indica tion than LDL C in ACS diagnosis. Conclusion: Serum apolipoprotein B/A1 ratio was an accurate and sensitive in dex to reflect abnormal of lipid metabolism during DM and ACS,it could be used for risk assessment of DM and ACS.
出处 《临床血液学杂志(输血与检验)》 CAS 2013年第6期837-840,共4页 Journal of Clinical Hematology(Blood Transfusion & Laboratory Medicine)
关键词 糖尿病 急性冠状动脉综合征 载脂蛋白A1 载脂蛋白B diabetes mellitus acute coronary syndrome apolipoprotein A apolipoprotein B
  • 相关文献

参考文献10

  • 1PETER W R, HERIBERT S. Diabetics with acute coro- nary syndrome: advances, challenges, and uncertainties [J]. Eur Heart J,2010,31:2971--2973.
  • 2RUSSELL M, SILVERMAN A, FLEG J I., et al. Achie- ving lipid targets in adults with type 2 diabetes:The stop atherosclerosis in native diabetics study[J]. J Clin Lipi- dol, 2010,4 : 435-- 443.
  • 3LAKSHMAN R, FOROUHI N G, SHARP S J, et al. Early age at menarche associated with cardiovascular dis- ease and mortality[J]. J Clin Endocrinol Metab, 2009,94 : 4953--4960.
  • 4SKURK T, ALBERTI-HUBER C, HERDER C, et al. Relationship between adipocyte size and adipokine expres- sion and secretion[J]. J Clin Endocrinol Metab, 2007,92 : 1023--1033.
  • 5DEAN G K. Intensive lowering of low-density lipoprotein cholesterol levels for primary prevention of coronary ar- tery disease[J]. Mayo Clin Proc, 2009 , 84 : 345- 352.
  • 6MILLER M. Lipid levels in the post-acute coronary syn- drome setting: Destabilizing another myth? [J]. J Am Coil Cardiol, 2008,51 : 1446 -- 1447.
  • 7刘晓辉,吴鹤,孙玉兰.急性心肌梗死早期的血脂分析[J].中国医师进修杂志(内科版),2006,29(4):52-53. 被引量:10
  • 8TASKINEN M R, BARTER P J, EHNHOLM C, et al. Ability of traditional lipid ratios and apolipoprotein ratios to predict cardiovascular risk in people with type 2 diabe- tes[J]. Diabetologia, 2010,53 : 1846-- 1855.
  • 9VALENSI P, PICARD S. Lipids, lipid-lowering therapy and diabetes complications[J]. Diabetes Metab, 2011,37 :15--24.
  • 10JAANA L, JOUKO S, GEORG A, et al. Apolipoprotein A-I, apolipoprotein B, and apolipoprotein B /apolipopro- tein A-I ratio:Reference intervals compared with values in different pathophysiological conditions from the FINRISK 2007 study[J]. Clinica Chimica Acta , 2011,412 :1146 -- 1150.

二级参考文献5

  • 1Benoit C, Despres JP, Moorjani S, et al. Tyiglycerides and HDLcholesterol as risk factor for ischemic heart disease. Results from the Que'bec Cardiovascular Study. Atherosclerosis, 1996, 119:235 -245.
  • 2Schonity G, Williamson E. High density lipoprotein metabolism reverse cholesterol transport and membrance protection. Curr Pin Lipidol, 1991,2:177 - 181.
  • 3Gore JM, Goldberg RJ, Matsumoto AS, et al. Validity of serum total cholesterol level obtained within 24 hours of acute myocardial infarction. Am J Cardiol, 1984,54: 722.
  • 4方圻,王钟林,宁田海,邵耕,陈在嘉,陆宗良,李健斋,林传骧,周北凡,诸骏仁,诸永康,陶萍,陶寿淇,龚兰生,顾复生,游凯,戴玉华.血脂异常防治建议[J].中华心血管病杂志,1997,25(3):169-175. 被引量:3067
  • 5陈阳,朱毅,谈中茹,顾薇,李瑾,张维,黄芸,郑柏生.脂代谢异常与冠状动脉病变关系的临床观察[J].国外医学(心血管疾病分册),2001,28(3):153-155. 被引量:9

共引文献9

同被引文献84

引证文献9

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部